Adjustments to timing or dose may help
Average body weight reduction: 5 mg weekly: 16.0% reduction (approximately 35 pounds for a 220-pound person) 10 mg weekly: 21.4% reduction (approximately 47 pounds) 15 mg weekly: 22.5% reduction (approximately 50 pounds) Placebo: 2.4% reduction Percentage of participants achieving clinically significant weight loss: 5% or more weight loss: 85% at 5 mg, 89% at 10 mg, 91% at 15 mg 10% or more weight loss: 69% at 5 mg, 78% at 10 mg, 84% at 15 mg 20% or more weight loss: 32% at 5 mg, 49% at 10 mg, 57% at 15 mg Look at those numbers carefully
It Works Around the Clock Studies using 24-hour blood pressure monitors show that GLP-1 medications lower blood pressure throughout the day and night
Semaglutide Peptide Research Specifications Compound: Semaglutide (GLP-1 receptor agonist analogue) CAS Number: 910463-68-2 Molecular Formula: CHNO Molecular Weight: ~4113.58 g/mol Peptide Sequence: H-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gln-Lys-Ala-Ala-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-NH Format: Lyophilised powder Quantity: 10mg per vial Purity: 99% by HPLC-MS analysis Testing: Third-party verified Janoshik Analytical Heavy metals & endotoxin: Screened per batch Storage: 20C lyophilised
Most patients begin experiencing appetite reduction and improved fullness signals within 3-5 days of starting compounded semaglutide injections, though peak effects typically emerge over 4-8 weeks as your body adjusts
